董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Feike Sijbesma | 男 | Chairman and Director | 66 | 20.63万 | 未持股 | 2026-02-19 |
| Peter Loscher | 男 | Director | 68 | 15.68万 | 未持股 | 2026-02-19 |
| Herna Verhagen | 女 | Director | 60 | 12.13万 | 未持股 | 2026-02-19 |
| Paul Stoffels | -- | Director | 64 | 17.73万 | 未持股 | 2026-02-19 |
| Marc Harrison | -- | Director | 62 | 12.63万 | 未持股 | 2026-02-19 |
| 蔡淑君 | 女 | Director | 68 | 14.03万 | 未持股 | 2026-02-19 |
| Liz Doherty | 女 | Director | 69 | 未披露 | 未持股 | 2026-02-19 |
| Benot Ribadeau Dumas | -- | Director | 54 | 未披露 | 未持股 | 2026-02-19 |
| Bob White | -- | Director | -- | 未披露 | 未持股 | 2026-02-19 |
| Indra K. Nooyi | 女 | Director | 70 | 13.13万 | 未持股 | 2026-02-19 |
| Sanjay Poonen | 男 | Director | 56 | 13.53万 | 未持股 | 2026-02-19 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Marnix van Ginneken | 男 | Chief ESG and Legal Officer | 53 | 141.68万 | 未持股 | 2026-02-19 |
| Roy Jakobs | 男 | Chief Executive Officer | 52 | 44.47万 | 未持股 | 2026-02-19 |
| Bert van Meurs | 男 | Chief Business Leader Diagnosis and Treatment and Executive Vice President | 65 | 未披露 | 未持股 | 2026-02-19 |
| Shez Partovi | -- | Chief Business Leader Enterprise Informatics and Chief Innovation Officer and Executive Vice President | 60 | 未披露 | 未持股 | 2026-02-19 |
| Willem Appelo | -- | Chief Operations Officer and Executive Vice President | 63 | 未披露 | 未持股 | 2026-02-19 |
| Deeptha Khanna | 女 | Chief Business Leader Personal Health and Executive Vice President | 50 | 未披露 | 未持股 | 2026-02-19 |
| Jeff DiLullo | -- | Chief Region Leader, Philips North America and Executive Vice President | 57 | 未披露 | 未持股 | 2026-02-19 |
| Heidi Sichien | -- | Chief People Officer and Executive Vice President | 52 | 未披露 | 未持股 | 2026-02-19 |
| Steve C de Baca | -- | Chief Patient Safety and Quality Officer and Executive Vice President | 58 | 未披露 | 未持股 | 2026-02-19 |
| Julia Strandberg | -- | Chief Business Leader Connected Care and Executive Vice President | 52 | 未披露 | 未持股 | 2026-02-19 |
| Charlotte Hanneman | 女 | Chief Financial Officer | 48 | 未披露 | 未持股 | 2026-02-19 |
| Ling Liu | -- | Chief Region Leader, Philips Greater China and Executive Vice President | 52 | 未披露 | 未持股 | 2026-02-19 |
| Ozlem Fidanci | -- | Chief of International Region and Executive Vice President | -- | 未披露 | 未持股 | 2026-02-19 |
| Jie Xue | -- | Chief Business Leader Diagnosis and Treatment and Executive Vice President | -- | 未披露 | 未持股 | 2026-02-19 |
董事简历
中英对照 | 中文 | 英文- Feike Sijbesma
-
Feike Sijbesma，荷兰国籍（男），于2014年11月被任命为委员会成员，涉及企业、责任、提名和公司治理（主席）。他目前任职Royal DSM N.V。（担任首席执行官兼管理委员会的主席）、De Nederlandsche Bank（监事会成员）、CEFIC （欧洲化学委员会）、CEFIC（欧洲化学委员会）。此前，他曾任职DSM Netherlands的监事会（担任主席）、Dutch Genomics Initiative （NGI）（成员）、Utrecht University （董事会成员）、Dutch Cancer Institute （NKI/AVL） （董事会成员）。
Feike Sijbesma,Former CEO of Koninklijke DSM NV (Honorary Chairman) and former non-executive Director of Unilever NV. Co-Chair of the Global Climate Adaptation Center and Member of the Board of Trustees of the World Economic Forum. - Feike Sijbesma，荷兰国籍（男），于2014年11月被任命为委员会成员，涉及企业、责任、提名和公司治理（主席）。他目前任职Royal DSM N.V。（担任首席执行官兼管理委员会的主席）、De Nederlandsche Bank（监事会成员）、CEFIC （欧洲化学委员会）、CEFIC（欧洲化学委员会）。此前，他曾任职DSM Netherlands的监事会（担任主席）、Dutch Genomics Initiative （NGI）（成员）、Utrecht University （董事会成员）、Dutch Cancer Institute （NKI/AVL） （董事会成员）。
- Feike Sijbesma,Former CEO of Koninklijke DSM NV (Honorary Chairman) and former non-executive Director of Unilever NV. Co-Chair of the Global Climate Adaptation Center and Member of the Board of Trustees of the World Economic Forum.
- Peter Loscher
-
Peter Loscher，西门子公司（Siemens AG）前总裁兼首席执行官，默克公司（Merck & Co.）全球人类健康总裁兼执行董事会成员，通用电气医疗保健生物科学公司（GE Healthcare biosciences）总裁兼首席执行官，通用电气公司执行委员会成员，Renova Management AG公司首席执行官兼董事会代表。目前是Telefónica S.A.和CaixaBank S.A.的董事会成员，Telefónica Deutschland Holding AG的监事会主席，Thyssen-Bornemisza Group AG和Doha Venture Capital LLC的非执行董事。
Peter Loscher,Former President and CEO of Siemens AG, President of Global Human Health and Member of the Executive Board of Merck & Co., President and CEO of GE Healthcare Bio-Sciences and member of GE's Corporate Executive Council, CEO and Delegate of the Board of Directors of Renova Management AG. Currently member of the Board of Directors of Telefónica S.A. and CaixaBank S.A. and Chairman of the Supervisory Board of Telefónica Deutschland Holding AG, Non-Executive Director of Thyssen-Bornemisza Group AG and Doha Venture Capital LLC. - Peter Loscher，西门子公司（Siemens AG）前总裁兼首席执行官，默克公司（Merck & Co.）全球人类健康总裁兼执行董事会成员，通用电气医疗保健生物科学公司（GE Healthcare biosciences）总裁兼首席执行官，通用电气公司执行委员会成员，Renova Management AG公司首席执行官兼董事会代表。目前是Telefónica S.A.和CaixaBank S.A.的董事会成员，Telefónica Deutschland Holding AG的监事会主席，Thyssen-Bornemisza Group AG和Doha Venture Capital LLC的非执行董事。
- Peter Loscher,Former President and CEO of Siemens AG, President of Global Human Health and Member of the Executive Board of Merck & Co., President and CEO of GE Healthcare Bio-Sciences and member of GE's Corporate Executive Council, CEO and Delegate of the Board of Directors of Renova Management AG. Currently member of the Board of Directors of Telefónica S.A. and CaixaBank S.A. and Chairman of the Supervisory Board of Telefónica Deutschland Holding AG, Non-Executive Director of Thyssen-Bornemisza Group AG and Doha Venture Capital LLC.
- Herna Verhagen
-
Herna Verhagen，荷兰国际监督者委员会的成员，提名委员会和HeTractGeBouw NV的赞助委员会，GooSkMeM丁基金会顾问委员会成员和VNO-NCW董事会成员。
Herna Verhagen,was appointed a member of the Supervisory Board at the annual general meeting on 23 April 2019, effective date 1 October 2019. - Herna Verhagen，荷兰国际监督者委员会的成员，提名委员会和HeTractGeBouw NV的赞助委员会，GooSkMeM丁基金会顾问委员会成员和VNO-NCW董事会成员。
- Herna Verhagen,was appointed a member of the Supervisory Board at the annual general meeting on 23 April 2019, effective date 1 October 2019.
- Paul Stoffels
-
Paul Stoffels，1962年出生于比利时。自2018年起担任监事会成员；第一任期于2022年届满。现任强生执行委员会副主席兼首席科学官。此前，曾任强生全球制药部主席、Virco首席执行官和Tibotec董事长。
Paul Stoffels,Former CEO of Virco, Chairman of Tibotec, worldwide Chair of Pharmaceuticals at Johnson & Johnson and Chief Scientific Officer & member of the Executive Committee at Johnson & Johnson. Currently CEO and Chairman of the Board of Directors of Galapagos NV. - Paul Stoffels，1962年出生于比利时。自2018年起担任监事会成员；第一任期于2022年届满。现任强生执行委员会副主席兼首席科学官。此前，曾任强生全球制药部主席、Virco首席执行官和Tibotec董事长。
- Paul Stoffels,Former CEO of Virco, Chairman of Tibotec, worldwide Chair of Pharmaceuticals at Johnson & Johnson and Chief Scientific Officer & member of the Executive Committee at Johnson & Johnson. Currently CEO and Chairman of the Board of Directors of Galapagos NV.
- Marc Harrison
-
Marc Harrison，自2018年起担任监事会成员；第一届任期于2022年届满。现任Intermountain 医疗保健公司总裁兼首席执行官。克利夫兰诊所前国际业务发展主管和克利夫兰诊所阿布扎比首席执行官。
Marc Harrison,Former President and Chief Executive Officer of Intermountain Healthcare and former Chief of International Business Development for Cleveland Clinic and Chief Executive Officer of Cleveland Clinic Abu Dhabi. Currently CEO HATCo (Health Assurance Transformation Company) at General Catalyst. - Marc Harrison，自2018年起担任监事会成员；第一届任期于2022年届满。现任Intermountain 医疗保健公司总裁兼首席执行官。克利夫兰诊所前国际业务发展主管和克利夫兰诊所阿布扎比首席执行官。
- Marc Harrison,Former President and Chief Executive Officer of Intermountain Healthcare and former Chief of International Business Development for Cleveland Clinic and Chief Executive Officer of Cleveland Clinic Abu Dhabi. Currently CEO HATCo (Health Assurance Transformation Company) at General Catalyst.
- 蔡淑君
-
蔡淑君，新加坡电信有限公司前集团首席执行官，任Prudential plc、Bharti Airtel Limited、Bharti Telecom Limited和Ayala Corporation董事会成员。新加坡总统顾问委员会成员，新加坡公共服务委员会副主席。于2022年5月1日获委任为保诚有限公司提名及企业管治委员会委员。
Chua Sock Koong was Chief Executive Officer of Singapore Telecommunications Limited (Singtel), Asia's leading communications technology group, having previoly held a number of senior roles at the firm, including Treasurer, Chief Executive Officer International and Group Chief Financial Officer. From April 2018 until March 2024, Sock Koong was a Non executive Director of Cap Vista Pte Ltd and, from March 2018 until March 2024, she was a Non executive Director of the Defence Science and Technology Agency.Sock Koong is a Fellow Member of the Institute of Singapore Chartered Accountants and a Chartered Financial Analyst. She holds a Bachelor's degree in Accountancy from the University of Singapore. - 蔡淑君，新加坡电信有限公司前集团首席执行官，任Prudential plc、Bharti Airtel Limited、Bharti Telecom Limited和Ayala Corporation董事会成员。新加坡总统顾问委员会成员，新加坡公共服务委员会副主席。于2022年5月1日获委任为保诚有限公司提名及企业管治委员会委员。
- Chua Sock Koong was Chief Executive Officer of Singapore Telecommunications Limited (Singtel), Asia's leading communications technology group, having previoly held a number of senior roles at the firm, including Treasurer, Chief Executive Officer International and Group Chief Financial Officer. From April 2018 until March 2024, Sock Koong was a Non executive Director of Cap Vista Pte Ltd and, from March 2018 until March 2024, she was a Non executive Director of the Defence Science and Technology Agency.Sock Koong is a Fellow Member of the Institute of Singapore Chartered Accountants and a Chartered Financial Analyst. She holds a Bachelor's degree in Accountancy from the University of Singapore.
- Liz Doherty
-
Liz Doherty，审计委员会主席。自2019年起担任监事会成员；第一任期将于2023年届满。Reckitt Benckiser Group PLC前CFO兼董事会成员，Brambles Ltd前CFO，Delhaize Group、Nokia Corp.、SABMiller PLC和Dunelm Group PLC前非执行董事兼审计委员会成员。现任Novartis AG监事会成员兼审计委员会女主席，英国特许管理会计师协会Corbion N.V.研究员。曾任英国司法部和女王陛下法院和法庭事务处（英国）非执行委员会成员。现为Agrolimen SA的子公司GBfoods SA和Affinity Petcare SA的顾问。
Liz Doherty,Currently, member of the Supervisory Board and Chairwoman of the audit committee of Novartis AG and of Corbion N.V. Member of the advisory committee of Freya Holdco S.à r.l. Fellow of the Chartered Institute of Management Accountants. Former CFO and board member of Reckitt Benckiser Group PLC, former CFO of Brambles Ltd, former non-executive director and audit committee member at Delhaize Group, Nokia Corp., SABMiller PLC and Dunelm Group PLC. Former non-executive board member of the UK Ministry of Justice and of Her Majesty's Courts and Tribunals Service (UK) and advisor to GBfoods SA and Affinity Petcare SA (subsidiaries of Agrolimen SA). - Liz Doherty，审计委员会主席。自2019年起担任监事会成员；第一任期将于2023年届满。Reckitt Benckiser Group PLC前CFO兼董事会成员，Brambles Ltd前CFO，Delhaize Group、Nokia Corp.、SABMiller PLC和Dunelm Group PLC前非执行董事兼审计委员会成员。现任Novartis AG监事会成员兼审计委员会女主席，英国特许管理会计师协会Corbion N.V.研究员。曾任英国司法部和女王陛下法院和法庭事务处（英国）非执行委员会成员。现为Agrolimen SA的子公司GBfoods SA和Affinity Petcare SA的顾问。
- Liz Doherty,Currently, member of the Supervisory Board and Chairwoman of the audit committee of Novartis AG and of Corbion N.V. Member of the advisory committee of Freya Holdco S.à r.l. Fellow of the Chartered Institute of Management Accountants. Former CFO and board member of Reckitt Benckiser Group PLC, former CFO of Brambles Ltd, former non-executive director and audit committee member at Delhaize Group, Nokia Corp., SABMiller PLC and Dunelm Group PLC. Former non-executive board member of the UK Ministry of Justice and of Her Majesty's Courts and Tribunals Service (UK) and advisor to GBfoods SA and Affinity Petcare SA (subsidiaries of Agrolimen SA).
- Benot Ribadeau Dumas
-
Beno t Ribadeau Dumas，SCOR前副首席执行官，法国总理前办公厅主任，Aerosystems前首席执行官，Zodiac Aerospace管理委员会成员，CGG Veritas前SEVP和Thales Underwater Systems前首席执行官。现任Exor董事总经理，Stellantis、Institut Merieux、Merieux Nutrisciences、BioMerieux、TagEnergy和Welltec的董事会成员。Galileo Global Education和Cerba Healthcare董事会成员。
Benot Ribadeau Dumas,Former deputy CEO at SCOR, former Chief of Staff to the French Prime Minister, former CEO of Aerosystems, member of the Management Board of Zodiac Aerospace, former SEVP CGG Veritas and former CEO of Thales Underwater Systems. Currently Managing Director at Exor, member of the Board of Directors of Stellantis, Institut Merieux, Merieux Nutrisciences, bioMerieux, TagEnergy and Welltec. Member of the Board of Directors of Galileo Global Education and Cerba Healthcare. - Beno t Ribadeau Dumas，SCOR前副首席执行官，法国总理前办公厅主任，Aerosystems前首席执行官，Zodiac Aerospace管理委员会成员，CGG Veritas前SEVP和Thales Underwater Systems前首席执行官。现任Exor董事总经理，Stellantis、Institut Merieux、Merieux Nutrisciences、BioMerieux、TagEnergy和Welltec的董事会成员。Galileo Global Education和Cerba Healthcare董事会成员。
- Benot Ribadeau Dumas,Former deputy CEO at SCOR, former Chief of Staff to the French Prime Minister, former CEO of Aerosystems, member of the Management Board of Zodiac Aerospace, former SEVP CGG Veritas and former CEO of Thales Underwater Systems. Currently Managing Director at Exor, member of the Board of Directors of Stellantis, Institut Merieux, Merieux Nutrisciences, bioMerieux, TagEnergy and Welltec. Member of the Board of Directors of Galileo Global Education and Cerba Healthcare.
- Bob White
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Indra K. Nooyi
-
Indra K. Nooyi，她于2015年4月至2020年4月担任Schlumberger Limited 董事。2006年成为百事的首席执行官，2007年被任命为Schlumberger N.V。董事会的主席。2001年她入选Schlumberger N.V。的董事会并担任总裁和首席财务官，2000年担任高级副总裁兼首席财务官。1996年到2000年她还担任百事公司战略和发展部的高级副总裁，1994年到1996年担任百事公司战略规划部的高级副总裁。在加入百事公司之前，她在Asea Brown Boveri股份有限公司规划和战略营销部担任了4年的高级副总裁，她也在摩托罗拉股份有限公司战略规划部的总监和副总裁。
Indra K. Nooyi was the Chief Executive Officer of PepsiCo, a multinational food, snack, and beverage company, from October 2006 to October 2018, where she also served as the Chair of its board of directors from May 2007 to February 2019. She was elected to PepsiCo's board of directors and became its President and Chief Financial Officer in 2001, and held leadership roles in finance and corporate strategy and development after joining PepsiCo in 1994.Director of Honeywell International Inc. since January 2026; director of Royal Philips since May 2021; director of Schlumberger Limited from April 2015 to April 2020.Member of the Dean's Advisory Council at MIT's School of Engineering since 2020.Trustee of Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, since 2020.Trustee of the National Gallery of Art since 2021. - Indra K. Nooyi，她于2015年4月至2020年4月担任Schlumberger Limited 董事。2006年成为百事的首席执行官，2007年被任命为Schlumberger N.V。董事会的主席。2001年她入选Schlumberger N.V。的董事会并担任总裁和首席财务官，2000年担任高级副总裁兼首席财务官。1996年到2000年她还担任百事公司战略和发展部的高级副总裁，1994年到1996年担任百事公司战略规划部的高级副总裁。在加入百事公司之前，她在Asea Brown Boveri股份有限公司规划和战略营销部担任了4年的高级副总裁，她也在摩托罗拉股份有限公司战略规划部的总监和副总裁。
- Indra K. Nooyi was the Chief Executive Officer of PepsiCo, a multinational food, snack, and beverage company, from October 2006 to October 2018, where she also served as the Chair of its board of directors from May 2007 to February 2019. She was elected to PepsiCo's board of directors and became its President and Chief Financial Officer in 2001, and held leadership roles in finance and corporate strategy and development after joining PepsiCo in 1994.Director of Honeywell International Inc. since January 2026; director of Royal Philips since May 2021; director of Schlumberger Limited from April 2015 to April 2020.Member of the Dean's Advisory Council at MIT's School of Engineering since 2020.Trustee of Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center, since 2020.Trustee of the National Gallery of Art since 2021.
- Sanjay Poonen
-
Sanjay Poonen，2013年8月起，担任VMware的执行副总裁、终端用户计算机产品总经理。加入VMware之前，他在SAP AG工作了7年多；2012年4月至2013年7月，担任其总裁、平台解决方案与移动部企业官；此前，2010年11月至2012年3月，担任全球解决方案总裁；2008年6月至2009年9月，担任性能优化应用执行副总裁；2006年4月至2008年6月，担任分析部高级副总裁。他在科技行业有着20多年的经验，曾在Symantec 和Veritas担任过行政级别的职务，还在Alphablox、Apple、Microsoft Corporation担任过产品管理和工程方面的职务。
Sanjay Poonen,Former Chief Operating Officer at VMware and President at SAP. Currently CEO and President of Cohesity and member of the Board of Directors of Snyk. - Sanjay Poonen，2013年8月起，担任VMware的执行副总裁、终端用户计算机产品总经理。加入VMware之前，他在SAP AG工作了7年多；2012年4月至2013年7月，担任其总裁、平台解决方案与移动部企业官；此前，2010年11月至2012年3月，担任全球解决方案总裁；2008年6月至2009年9月，担任性能优化应用执行副总裁；2006年4月至2008年6月，担任分析部高级副总裁。他在科技行业有着20多年的经验，曾在Symantec 和Veritas担任过行政级别的职务，还在Alphablox、Apple、Microsoft Corporation担任过产品管理和工程方面的职务。
- Sanjay Poonen,Former Chief Operating Officer at VMware and President at SAP. Currently CEO and President of Cohesity and member of the Board of Directors of Snyk.
高管简历
中英对照 | 中文 | 英文- Marnix van Ginneken
Marnix van Ginneken， 集团职责：法律和普通秘书。
Marnix van Ginneken became a member of the Executive Committee in 2014 and was appointed a member of Philips' Board of Management in 2017. He is responsible for driving Environmental, Social and Governance efforts across the company, including stainability. Marnix is also responsible for Legal, Intellectual Property & Standards, Government & Public Affairs and Communications & Brand. He became Chair of the Board of the Philips Foundation in 2024. He has also been a Professor of International Corporate Governance at the Erasm School of Law in Rotterdam since 2011. In 2025, Marnix was appointed to the Dutch Monitoring Committee Corporate Governance Code by the Minister of Economic Affairs. Before joining Philips in 2007, Marnix worked for Akzo Nobel, and prior to that he was an attorney in private practice.- Marnix van Ginneken， 集团职责：法律和普通秘书。
- Marnix van Ginneken became a member of the Executive Committee in 2014 and was appointed a member of Philips' Board of Management in 2017. He is responsible for driving Environmental, Social and Governance efforts across the company, including stainability. Marnix is also responsible for Legal, Intellectual Property & Standards, Government & Public Affairs and Communications & Brand. He became Chair of the Board of the Philips Foundation in 2024. He has also been a Professor of International Corporate Governance at the Erasm School of Law in Rotterdam since 2011. In 2025, Marnix was appointed to the Dutch Monitoring Committee Corporate Governance Code by the Minister of Economic Affairs. Before joining Philips in 2007, Marnix worked for Akzo Nobel, and prior to that he was an attorney in private practice.
- Roy Jakobs
罗伊·雅各布斯，1974年出生于荷兰/德国。执行副总裁，首席业务负责人个人健康。
Roy Jakobs joined Philips in 2010 and has held vario global leadership positions across the company, starting as Chief Marketing & Strategy Officer for Philips Lighting. In 2012, he became Market Leader for Philips Middle East & Turkey, leading the Healthcare, Consumer, and Lighting binesses out of Dubai. Subsequently, he became global Biness Leader of Domestic Appliances, based in Shanghai, in 2015. In 2018, Roy joined the Executive Committee as Chief Biness Leader of Personal Health and in early 2020 he started as Chief Biness Leader of Connected Care. As Chief Executive Officer and Chairman of the Board of Management and the Executive Committee, he also holds direct responsibility for Patient Safety and Quality, Medical Office, and Internal Audit. Prior to his career at Philips, he held vario management positions at Royal Dutch Shell and RELX.- 罗伊·雅各布斯，1974年出生于荷兰/德国。执行副总裁，首席业务负责人个人健康。
- Roy Jakobs joined Philips in 2010 and has held vario global leadership positions across the company, starting as Chief Marketing & Strategy Officer for Philips Lighting. In 2012, he became Market Leader for Philips Middle East & Turkey, leading the Healthcare, Consumer, and Lighting binesses out of Dubai. Subsequently, he became global Biness Leader of Domestic Appliances, based in Shanghai, in 2015. In 2018, Roy joined the Executive Committee as Chief Biness Leader of Personal Health and in early 2020 he started as Chief Biness Leader of Connected Care. As Chief Executive Officer and Chairman of the Board of Management and the Executive Committee, he also holds direct responsibility for Patient Safety and Quality, Medical Office, and Internal Audit. Prior to his career at Philips, he held vario management positions at Royal Dutch Shell and RELX.
- Bert van Meurs
Bert van Meurs，1961年出生于荷兰。执行副总裁，图像引导治疗首席业务负责人，共同负责诊断和治疗。
Bert van Meurs joined the Supervisory Board and the Nomination & Governance Committee in April 2024. He is a member of the Executive Committee at Royal Philips N.V. of the Netherlands, where he serves as Executive Vice President and Chief Biness Leader of Image Guided Therapy, and also as Chief Biness Leader of Precision Diagnosis (ad interim) responsible for Diagnosis and Treatment. He has more than 40 years of experience since joining Philips in 1985 in vario global biness leadership positions. He has a master's degree in physics from the University of Utrecht and a degree in biness marketing from the Technical University of Eindhoven, both in the Netherlands.- Bert van Meurs，1961年出生于荷兰。执行副总裁，图像引导治疗首席业务负责人，共同负责诊断和治疗。
- Bert van Meurs joined the Supervisory Board and the Nomination & Governance Committee in April 2024. He is a member of the Executive Committee at Royal Philips N.V. of the Netherlands, where he serves as Executive Vice President and Chief Biness Leader of Image Guided Therapy, and also as Chief Biness Leader of Precision Diagnosis (ad interim) responsible for Diagnosis and Treatment. He has more than 40 years of experience since joining Philips in 1985 in vario global biness leadership positions. He has a master's degree in physics from the University of Utrecht and a degree in biness marketing from the Technical University of Eindhoven, both in the Netherlands.
- Shez Partovi
Shez Partovi，于2021年加入飞利浦，在医疗保健、生命科学和基因组学行业拥有30多年领导大健康系统、云转型以及人工智能和机器学习计划的经验。
Shez Partovi,joined Philips in 2021 and has more than 30 years of experience leading large health systems, cloud transformation, and artificial intelligence and machine learning initiatives in the healthcare, life sciences and genomics industries.- Shez Partovi，于2021年加入飞利浦，在医疗保健、生命科学和基因组学行业拥有30多年领导大健康系统、云转型以及人工智能和机器学习计划的经验。
- Shez Partovi,joined Philips in 2021 and has more than 30 years of experience leading large health systems, cloud transformation, and artificial intelligence and machine learning initiatives in the healthcare, life sciences and genomics industries.
- Willem Appelo
Willem Appelo，于2022年加入飞利浦，在金融和供应链管理方面拥有超过30年的技术和医疗器械技术行业经验。
Willem Appelo,joined Philips in 2022,has over 30 years of experience in technology and the medical device technology industry in finance and supply chain management.- Willem Appelo，于2022年加入飞利浦，在金融和供应链管理方面拥有超过30年的技术和医疗器械技术行业经验。
- Willem Appelo,joined Philips in 2022,has over 30 years of experience in technology and the medical device technology industry in finance and supply chain management.
- Deeptha Khanna
Deeptha Khanna，目前是皇家飞利浦（一家健康技术公司）的执行副总裁兼首席商业领袖，负责个人健康，她自2020年以来一直担任该职位，同时在公司执行委员会任职。在加入飞利浦之前，她在强生公司（Johnson & Johnson）担任越来越重要的职位，包括2019年至2020年担任皮肤健康和营销价值办公室全球总裁；全球婴儿护理总裁，从2017年到2019年；2015年至2017年，担任亚太和全球新兴市场婴儿护理副总裁。在加入Johnson & Johnson之前，她还在Procter & Gamble工作了17年。
Deeptha Khanna,Executive Vice President and Chief Business Leader, Personal Health, of Royal Philips, a health technology company, since 2020, while also serving on the company's Executive Committee;Held positions of increasing responsibility at Johnson & Johnson, including Global President, Skin Health and Office of Marketing Value, from 2019 to 2020; Global President, Baby Care, from 2017 to 2019; and Vice President, Baby Care, Asia Pacific and Global Emerging Markets, from 2015 to 2017;Held positions of increasing responsibility at Procter & Gamble from 1998 to 2015.- Deeptha Khanna，目前是皇家飞利浦（一家健康技术公司）的执行副总裁兼首席商业领袖，负责个人健康，她自2020年以来一直担任该职位，同时在公司执行委员会任职。在加入飞利浦之前，她在强生公司（Johnson & Johnson）担任越来越重要的职位，包括2019年至2020年担任皮肤健康和营销价值办公室全球总裁；全球婴儿护理总裁，从2017年到2019年；2015年至2017年，担任亚太和全球新兴市场婴儿护理副总裁。在加入Johnson & Johnson之前，她还在Procter & Gamble工作了17年。
- Deeptha Khanna,Executive Vice President and Chief Business Leader, Personal Health, of Royal Philips, a health technology company, since 2020, while also serving on the company's Executive Committee;Held positions of increasing responsibility at Johnson & Johnson, including Global President, Skin Health and Office of Marketing Value, from 2019 to 2020; Global President, Baby Care, from 2017 to 2019; and Vice President, Baby Care, Asia Pacific and Global Emerging Markets, from 2015 to 2017;Held positions of increasing responsibility at Procter & Gamble from 1998 to 2015.
- Jeff DiLullo
Jeff DiLullo，2019年加入飞利浦，在美国陆军和信息技术行业拥有30多年的领导经验。
Jeff DiLullo,joined Philips in 2019, drawing on more than 30 years of leadership experience in the US Army and the information technology industry.- Jeff DiLullo，2019年加入飞利浦，在美国陆军和信息技术行业拥有30多年的领导经验。
- Jeff DiLullo,joined Philips in 2019, drawing on more than 30 years of leadership experience in the US Army and the information technology industry.
- Heidi Sichien
Heidi Sichien，2006年加入飞利浦，在公司多个部门的人力资源领导角色方面拥有超过18年的经验。
Heidi Sichien,joined Philips in 2006 and has over 18 years of experience in leadership roles in HR across many parts of the company.- Heidi Sichien，2006年加入飞利浦，在公司多个部门的人力资源领导角色方面拥有超过18年的经验。
- Heidi Sichien,joined Philips in 2006 and has over 18 years of experience in leadership roles in HR across many parts of the company.
- Steve C de Baca
Steve C de Baca，于2023年加入飞利浦，在医疗技术行业拥有超过30年的质量和监管事务经验。
Steve C de Baca,joined Philips in 2023 and has over 30 years of quality and regulatory affairs experience in the medical technology industry.- Steve C de Baca，于2023年加入飞利浦，在医疗技术行业拥有超过30年的质量和监管事务经验。
- Steve C de Baca,joined Philips in 2023 and has over 30 years of quality and regulatory affairs experience in the medical technology industry.
- Julia Strandberg
Julia Strandberg，2023年加入飞利浦，在医疗技术行业拥有20年领导经验。
Julia Strandberg,joined Philips in 2023 and has 20 years of leadership experience in the medical technology industry.- Julia Strandberg，2023年加入飞利浦，在医疗技术行业拥有20年领导经验。
- Julia Strandberg,joined Philips in 2023 and has 20 years of leadership experience in the medical technology industry.
- Charlotte Hanneman
Charlotte Hanneman，于2024年加入飞利浦，负责财务，包括投资者关系和并购，以及房地产和安全。在加入飞利浦之前，Charlotte曾在全球医疗技术公司史赛克担任财务总监兼财务规划与分析主管。在此之前，夏洛特曾在多家跨国医疗保健公司担任国际金融领导职务。
Charlotte Hanneman joined Philips in 2024 and is responsible for Finance, including Investor Relations, Strategy and M&A, as ll as Real Estate and Security. Prior to joining Philips, Charlotte served as Controller and Head of Financial Planning & Analysis at global medical technology company Stryker. In this role, she was responsible for external reporting, enterprise financial planning and analysis, and biness development finance. She also oversaw indirect procurement and had direct responsibility for finance teams across Europe, the Middle East and Africa, Canada, and Latin America. Earlier in her career, Charlotte held several international finance leadership roles at Stryker and other multinational healthcare companies, including Merck, Schering Plough and Organon. She has extensive experience working in the and has lived in multiple countries across Asia and Europe.- Charlotte Hanneman，于2024年加入飞利浦，负责财务，包括投资者关系和并购，以及房地产和安全。在加入飞利浦之前，Charlotte曾在全球医疗技术公司史赛克担任财务总监兼财务规划与分析主管。在此之前，夏洛特曾在多家跨国医疗保健公司担任国际金融领导职务。
- Charlotte Hanneman joined Philips in 2024 and is responsible for Finance, including Investor Relations, Strategy and M&A, as ll as Real Estate and Security. Prior to joining Philips, Charlotte served as Controller and Head of Financial Planning & Analysis at global medical technology company Stryker. In this role, she was responsible for external reporting, enterprise financial planning and analysis, and biness development finance. She also oversaw indirect procurement and had direct responsibility for finance teams across Europe, the Middle East and Africa, Canada, and Latin America. Earlier in her career, Charlotte held several international finance leadership roles at Stryker and other multinational healthcare companies, including Merck, Schering Plough and Organon. She has extensive experience working in the and has lived in multiple countries across Asia and Europe.
- Ling Liu
刘玲，1998年加入飞利浦，在大中华区、荷兰和北美拥有超过26年的领导职务经验。
Ling Liu,joined Philips in 1998 and has more than 26 years' experience in leadership roles in Greater China, the Netherlands and North America.- 刘玲，1998年加入飞利浦，在大中华区、荷兰和北美拥有超过26年的领导职务经验。
- Ling Liu,joined Philips in 1998 and has more than 26 years' experience in leadership roles in Greater China, the Netherlands and North America.
- Ozlem Fidanci
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Jie Xue
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介